RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer

Cancer Cell - United States
doi 10.1016/j.ccell.2018.10.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Noncanonical Autophagy in Myeloid Cells Drives Tumor Immune Tolerance

Cancer Discovery
Oncology
2018English

Oncogenic KRAS Drives Immune Suppression in Colorectal Cancer

Cancer Cell
Cancer ResearchOncologyCell Biology
2019English

Nemo-Like Kinase Drives Foxp3 Stability and Is Critical for Maintenance of Immune Tolerance by Regulatory T Cells

Cell Reports
BiochemistryGeneticsMolecular Biology
2019English

CRISPR-mediated Adaptive Immune System in E. Coli

English

Small Molecule Tyrosine Kinase Inhibitors in Pancreatic Cancer

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma

Cell Reports
BiochemistryGeneticsMolecular Biology
2018English

Adaptive Phenotype Drives Resistance to Androgen Deprivation Therapy in Prostate Cancer

Cell Communication and Signaling
BiochemistryCell BiologyMolecular Biology
2017English

Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Wheatgerm Agglutinin-Mediated Toxicity in Pancreatic Cancer Cells

British Journal of Cancer
Cancer ResearchOncology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy